Frequently Asked Questions

EMDrugs is a unique source of information about drugs used in the emergency department. We cover indications, dosages, cautions, updated literature reviews, and more.

Our objective is to provide the highest quality content on pharmacology as applied to Emergency Medicine. All content is written and edited by specialist emergency physicians, in collaboration with other healthcare professionals.

It is designed to serve as a point-of-care tool for emergency physicians and trainees, clinical pharmacologists, general practitioners, physician assistants, nurse practitioners, and other professionals involved in emergency healthcare.

EMDrugs was founded in Chile in 2021 by Cristóbal Sáa, MD, an emergency medicine specialist. He leads the project and serves as the editor-in-chief.

Content: The content is written by emergency physicians and is backed by more than 1,000 scientific references.

Reach: We currently have hundreds of users worldwide, following the launch of our initial website at the historic first FLAME (Latin American Federation of Emergency Medicine) congress in Buenos Aires, Argentina, in 2024.

Our Team:

• Cristóbal Sáa: Founder, Content, Editor-in-Chief
• José Pedro Sepúlveda: Co-Founder, Content, Pharmacology Advisor
• Juan Ignacio Sáa: Co-Founder, CTO
• Joaquín Chuecas: Content, Toxicology Advisor
• Diego Schmidt: Graphic Design
• Olenhka Cepeda: Scientific Archivist

We are grateful to those who have contributed to EMDrugs, particularly Fernando Segura, Co-Founder and Former COO.

Important: Scientific and pharmacological content is NOT generated in any way by artificial intelligence or language models. These tools are used solely for orthography and grammatical purposes. All content is written by licensed physicians based on their own narrative reviews of literature.

We specialize in clinical pharmacology in emergency medicine (EM). Our focus is on describing medications in a practical and concise manner to ensure their most appropriate use, utilizing the latest available evidence.

Our core content includes drug descriptions, as well as comparative tables of related medications, some categorized by pharmacological similarity and others by clinical use. We feature a selection of medications most relevant to EM, and our content is continually expanding and being updated.

Examples of our content include:

• Induction agents and neuromuscular blocking agents
• Fibrinolytic therapy
• Vasopressors and inodilators
• Bronchodilators
• Anticonvulsant drugs
• Biological products and immunization
• Principles of toxicology, decontamination, and antidotes

Read our Terms for more information on our Disclaimer, Copyright, and Privacy Policy.

Our value

• The difference between EMDrugs and other sources of information is our focus on providing a practical approach to pharmacology from the perspective of emergency medicine.

• EMDrugs aims to introduce and familiarize the healthcare team with drugs and their usage through an executive summary, as well as specific sections that describe the role of the drug in particular indications or pathologies.

• We focus on describing the most appropriate way to use medications, detailing which indications (labeled or off-label) have solid evidence and which do not.

Limitations

• We cover commonly prescribed medications in the emergency department, though not all of them.

• EMDrugs complements other drug databases, such as drug interaction checkers, pregnancy and lactation databases, and drug banks containing thousands of medications approved for human use.

Yes, EMDrugs offers open-access Executive Summaries of medications.

Additionally, we provide extended descriptions of these medications and comparative tables with updated references, available for an accessible annual subscription fee.